Global Inactivated Influenza Virus Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
The global Inactivated Influenza Virus Vaccine market size was estimated at USD 8250.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Inactivated Influenza Virus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Inactivated Influenza Virus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Inactivated Influenza Virus Vaccine market
Global Inactivated Influenza Virus Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Jiangsu Jindik Biotechnology Co.Ltd
Beijing Kexing Biological Products Co.Ltd
Jiangsu Kangrun Biotechnology Co.Ltd
Hualan Bio Vaccines Co.Ltd
Dalian Yalifeng Biopharmaceutical Co.Ltd
Shanghai Institute of Biological Products Co.Ltd
Changchun Institute of Biological Products Co.Ltd
Lanzhou Institute of Biological Products Co.Ltd
Zhejiang Tian Yuan Biopharmaceutical Co.Ltd
Emmi Chengxin Biopharmaceutical Co.Ltd
Market Segmentation (by Type)
Whole Virus Vaccine
Subunit Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Inactivated Influenza Virus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Inactivated Influenza Virus Vaccine market size was estimated at USD 8250.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Inactivated Influenza Virus Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Inactivated Influenza Virus Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Inactivated Influenza Virus Vaccine market
Global Inactivated Influenza Virus Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Jiangsu Jindik Biotechnology Co.Ltd
Beijing Kexing Biological Products Co.Ltd
Jiangsu Kangrun Biotechnology Co.Ltd
Hualan Bio Vaccines Co.Ltd
Dalian Yalifeng Biopharmaceutical Co.Ltd
Shanghai Institute of Biological Products Co.Ltd
Changchun Institute of Biological Products Co.Ltd
Lanzhou Institute of Biological Products Co.Ltd
Zhejiang Tian Yuan Biopharmaceutical Co.Ltd
Emmi Chengxin Biopharmaceutical Co.Ltd
Market Segmentation (by Type)
Whole Virus Vaccine
Subunit Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Inactivated Influenza Virus Vaccine Market
- Overview of the regional outlook of the Inactivated Influenza Virus Vaccine Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Inactivated Influenza Virus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Inactivated Influenza Virus Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Virus Vaccine Segment by Type
1.2.2 Inactivated Influenza Virus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED INFLUENZA VIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Inactivated Influenza Virus Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED INFLUENZA VIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inactivated Influenza Virus Vaccine Product Life Cycle
3.3 Global Inactivated Influenza Virus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Influenza Virus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inactivated Influenza Virus Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Influenza Virus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Influenza Virus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INACTIVATED INFLUENZA VIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Influenza Virus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED INFLUENZA VIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Influenza Virus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inactivated Influenza Virus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Inactivated Influenza Virus Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Inactivated Influenza Virus Vaccine Price by Type (2020-2025)
7 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Virus Vaccine Market Sales by Application (2020-2025)
7.3 Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2020-2025)
8 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SALES BY REGION
8.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Region
8.2 Global Inactivated Influenza Virus Vaccine Market Size by Region
8.2.1 Global Inactivated Influenza Virus Vaccine Market Size by Region
8.2.2 Global Inactivated Influenza Virus Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Inactivated Influenza Virus Vaccine Sales by Country
8.3.2 North America Inactivated Influenza Virus Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inactivated Influenza Virus Vaccine Sales by Country
8.4.2 Europe Inactivated Influenza Virus Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region
8.5.2 Asia Pacific Inactivated Influenza Virus Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inactivated Influenza Virus Vaccine Sales by Country
8.6.2 South America Inactivated Influenza Virus Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region
8.7.2 Middle East and Africa Inactivated Influenza Virus Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INACTIVATED INFLUENZA VIRUS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Inactivated Influenza Virus Vaccine by Region(2020-2025)
9.2 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inactivated Influenza Virus Vaccine Production
9.4.1 North America Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inactivated Influenza Virus Vaccine Production
9.5.1 Europe Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inactivated Influenza Virus Vaccine Production (2020-2025)
9.6.1 Japan Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inactivated Influenza Virus Vaccine Production (2020-2025)
9.7.1 China Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.7.2 China Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Inactivated Influenza Virus Vaccine Product Overview
10.1.3 CSL Inactivated Influenza Virus Vaccine Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Inactivated Influenza Virus Vaccine Product Overview
10.2.3 GSK Inactivated Influenza Virus Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
10.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Mylan
10.4.1 Mylan Basic Information
10.4.2 Mylan Inactivated Influenza Virus Vaccine Product Overview
10.4.3 Mylan Inactivated Influenza Virus Vaccine Product Market Performance
10.4.4 Mylan Business Overview
10.4.5 Mylan Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
10.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Inactivated Influenza Virus Vaccine Product Overview
10.6.3 Pfizer Inactivated Influenza Virus Vaccine Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Johnson and Johnson
10.7.1 Johnson and Johnson Basic Information
10.7.2 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
10.7.3 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Market Performance
10.7.4 Johnson and Johnson Business Overview
10.7.5 Johnson and Johnson Recent Developments
10.8 Jiangsu Jindik Biotechnology Co.Ltd
10.8.1 Jiangsu Jindik Biotechnology Co.Ltd Basic Information
10.8.2 Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.8.3 Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.8.4 Jiangsu Jindik Biotechnology Co.Ltd Business Overview
10.8.5 Jiangsu Jindik Biotechnology Co.Ltd Recent Developments
10.9 Beijing Kexing Biological Products Co.Ltd
10.9.1 Beijing Kexing Biological Products Co.Ltd Basic Information
10.9.2 Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.9.3 Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.9.4 Beijing Kexing Biological Products Co.Ltd Business Overview
10.9.5 Beijing Kexing Biological Products Co.Ltd Recent Developments
10.10 Jiangsu Kangrun Biotechnology Co.Ltd
10.10.1 Jiangsu Kangrun Biotechnology Co.Ltd Basic Information
10.10.2 Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.10.3 Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.10.4 Jiangsu Kangrun Biotechnology Co.Ltd Business Overview
10.10.5 Jiangsu Kangrun Biotechnology Co.Ltd Recent Developments
10.11 Hualan Bio Vaccines Co.Ltd
10.11.1 Hualan Bio Vaccines Co.Ltd Basic Information
10.11.2 Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.11.3 Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.11.4 Hualan Bio Vaccines Co.Ltd Business Overview
10.11.5 Hualan Bio Vaccines Co.Ltd Recent Developments
10.12 Dalian Yalifeng Biopharmaceutical Co.Ltd
10.12.1 Dalian Yalifeng Biopharmaceutical Co.Ltd Basic Information
10.12.2 Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.12.3 Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.12.4 Dalian Yalifeng Biopharmaceutical Co.Ltd Business Overview
10.12.5 Dalian Yalifeng Biopharmaceutical Co.Ltd Recent Developments
10.13 Shanghai Institute of Biological Products Co.Ltd
10.13.1 Shanghai Institute of Biological Products Co.Ltd Basic Information
10.13.2 Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.13.3 Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.13.4 Shanghai Institute of Biological Products Co.Ltd Business Overview
10.13.5 Shanghai Institute of Biological Products Co.Ltd Recent Developments
10.14 Changchun Institute of Biological Products Co.Ltd
10.14.1 Changchun Institute of Biological Products Co.Ltd Basic Information
10.14.2 Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.14.3 Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.14.4 Changchun Institute of Biological Products Co.Ltd Business Overview
10.14.5 Changchun Institute of Biological Products Co.Ltd Recent Developments
10.15 Lanzhou Institute of Biological Products Co.Ltd
10.15.1 Lanzhou Institute of Biological Products Co.Ltd Basic Information
10.15.2 Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.15.3 Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.15.4 Lanzhou Institute of Biological Products Co.Ltd Business Overview
10.15.5 Lanzhou Institute of Biological Products Co.Ltd Recent Developments
10.16 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd
10.16.1 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Basic Information
10.16.2 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.16.3 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.16.4 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Business Overview
10.16.5 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Recent Developments
10.17 Emmi Chengxin Biopharmaceutical Co.Ltd
10.17.1 Emmi Chengxin Biopharmaceutical Co.Ltd Basic Information
10.17.2 Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.17.3 Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.17.4 Emmi Chengxin Biopharmaceutical Co.Ltd Business Overview
10.17.5 Emmi Chengxin Biopharmaceutical Co.Ltd Recent Developments
11 INACTIVATED INFLUENZA VIRUS VACCINE MARKET FORECAST BY REGION
11.1 Global Inactivated Influenza Virus Vaccine Market Size Forecast
11.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region
11.2.4 South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inactivated Influenza Virus Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Inactivated Influenza Virus Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Inactivated Influenza Virus Vaccine by Type (2026-2033)
12.1.2 Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Inactivated Influenza Virus Vaccine by Type (2026-2033)
12.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Inactivated Influenza Virus Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Inactivated Influenza Virus Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Virus Vaccine Segment by Type
1.2.2 Inactivated Influenza Virus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED INFLUENZA VIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Inactivated Influenza Virus Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED INFLUENZA VIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inactivated Influenza Virus Vaccine Product Life Cycle
3.3 Global Inactivated Influenza Virus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Influenza Virus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inactivated Influenza Virus Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Influenza Virus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Influenza Virus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INACTIVATED INFLUENZA VIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Influenza Virus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED INFLUENZA VIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Influenza Virus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inactivated Influenza Virus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Inactivated Influenza Virus Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Inactivated Influenza Virus Vaccine Price by Type (2020-2025)
7 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Virus Vaccine Market Sales by Application (2020-2025)
7.3 Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2020-2025)
8 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SALES BY REGION
8.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Region
8.2 Global Inactivated Influenza Virus Vaccine Market Size by Region
8.2.1 Global Inactivated Influenza Virus Vaccine Market Size by Region
8.2.2 Global Inactivated Influenza Virus Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Inactivated Influenza Virus Vaccine Sales by Country
8.3.2 North America Inactivated Influenza Virus Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inactivated Influenza Virus Vaccine Sales by Country
8.4.2 Europe Inactivated Influenza Virus Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region
8.5.2 Asia Pacific Inactivated Influenza Virus Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inactivated Influenza Virus Vaccine Sales by Country
8.6.2 South America Inactivated Influenza Virus Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region
8.7.2 Middle East and Africa Inactivated Influenza Virus Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INACTIVATED INFLUENZA VIRUS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Inactivated Influenza Virus Vaccine by Region(2020-2025)
9.2 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inactivated Influenza Virus Vaccine Production
9.4.1 North America Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inactivated Influenza Virus Vaccine Production
9.5.1 Europe Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inactivated Influenza Virus Vaccine Production (2020-2025)
9.6.1 Japan Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inactivated Influenza Virus Vaccine Production (2020-2025)
9.7.1 China Inactivated Influenza Virus Vaccine Production Growth Rate (2020-2025)
9.7.2 China Inactivated Influenza Virus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Inactivated Influenza Virus Vaccine Product Overview
10.1.3 CSL Inactivated Influenza Virus Vaccine Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Inactivated Influenza Virus Vaccine Product Overview
10.2.3 GSK Inactivated Influenza Virus Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
10.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Mylan
10.4.1 Mylan Basic Information
10.4.2 Mylan Inactivated Influenza Virus Vaccine Product Overview
10.4.3 Mylan Inactivated Influenza Virus Vaccine Product Market Performance
10.4.4 Mylan Business Overview
10.4.5 Mylan Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
10.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Inactivated Influenza Virus Vaccine Product Overview
10.6.3 Pfizer Inactivated Influenza Virus Vaccine Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Johnson and Johnson
10.7.1 Johnson and Johnson Basic Information
10.7.2 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
10.7.3 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Market Performance
10.7.4 Johnson and Johnson Business Overview
10.7.5 Johnson and Johnson Recent Developments
10.8 Jiangsu Jindik Biotechnology Co.Ltd
10.8.1 Jiangsu Jindik Biotechnology Co.Ltd Basic Information
10.8.2 Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.8.3 Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.8.4 Jiangsu Jindik Biotechnology Co.Ltd Business Overview
10.8.5 Jiangsu Jindik Biotechnology Co.Ltd Recent Developments
10.9 Beijing Kexing Biological Products Co.Ltd
10.9.1 Beijing Kexing Biological Products Co.Ltd Basic Information
10.9.2 Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.9.3 Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.9.4 Beijing Kexing Biological Products Co.Ltd Business Overview
10.9.5 Beijing Kexing Biological Products Co.Ltd Recent Developments
10.10 Jiangsu Kangrun Biotechnology Co.Ltd
10.10.1 Jiangsu Kangrun Biotechnology Co.Ltd Basic Information
10.10.2 Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.10.3 Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.10.4 Jiangsu Kangrun Biotechnology Co.Ltd Business Overview
10.10.5 Jiangsu Kangrun Biotechnology Co.Ltd Recent Developments
10.11 Hualan Bio Vaccines Co.Ltd
10.11.1 Hualan Bio Vaccines Co.Ltd Basic Information
10.11.2 Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.11.3 Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.11.4 Hualan Bio Vaccines Co.Ltd Business Overview
10.11.5 Hualan Bio Vaccines Co.Ltd Recent Developments
10.12 Dalian Yalifeng Biopharmaceutical Co.Ltd
10.12.1 Dalian Yalifeng Biopharmaceutical Co.Ltd Basic Information
10.12.2 Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.12.3 Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.12.4 Dalian Yalifeng Biopharmaceutical Co.Ltd Business Overview
10.12.5 Dalian Yalifeng Biopharmaceutical Co.Ltd Recent Developments
10.13 Shanghai Institute of Biological Products Co.Ltd
10.13.1 Shanghai Institute of Biological Products Co.Ltd Basic Information
10.13.2 Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.13.3 Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.13.4 Shanghai Institute of Biological Products Co.Ltd Business Overview
10.13.5 Shanghai Institute of Biological Products Co.Ltd Recent Developments
10.14 Changchun Institute of Biological Products Co.Ltd
10.14.1 Changchun Institute of Biological Products Co.Ltd Basic Information
10.14.2 Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.14.3 Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.14.4 Changchun Institute of Biological Products Co.Ltd Business Overview
10.14.5 Changchun Institute of Biological Products Co.Ltd Recent Developments
10.15 Lanzhou Institute of Biological Products Co.Ltd
10.15.1 Lanzhou Institute of Biological Products Co.Ltd Basic Information
10.15.2 Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.15.3 Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.15.4 Lanzhou Institute of Biological Products Co.Ltd Business Overview
10.15.5 Lanzhou Institute of Biological Products Co.Ltd Recent Developments
10.16 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd
10.16.1 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Basic Information
10.16.2 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.16.3 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.16.4 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Business Overview
10.16.5 Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Recent Developments
10.17 Emmi Chengxin Biopharmaceutical Co.Ltd
10.17.1 Emmi Chengxin Biopharmaceutical Co.Ltd Basic Information
10.17.2 Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
10.17.3 Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Market Performance
10.17.4 Emmi Chengxin Biopharmaceutical Co.Ltd Business Overview
10.17.5 Emmi Chengxin Biopharmaceutical Co.Ltd Recent Developments
11 INACTIVATED INFLUENZA VIRUS VACCINE MARKET FORECAST BY REGION
11.1 Global Inactivated Influenza Virus Vaccine Market Size Forecast
11.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region
11.2.4 South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inactivated Influenza Virus Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Inactivated Influenza Virus Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Inactivated Influenza Virus Vaccine by Type (2026-2033)
12.1.2 Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Inactivated Influenza Virus Vaccine by Type (2026-2033)
12.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Inactivated Influenza Virus Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inactivated Influenza Virus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Inactivated Influenza Virus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Inactivated Influenza Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Inactivated Influenza Virus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Virus Vaccine as of 2024)
Table 10. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Inactivated Influenza Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Inactivated Influenza Virus Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Inactivated Influenza Virus Vaccine Sales by Type (K MT)
Table 26. Global Inactivated Influenza Virus Vaccine Market Size by Type (M USD)
Table 27. Global Inactivated Influenza Virus Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Inactivated Influenza Virus Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Inactivated Influenza Virus Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Inactivated Influenza Virus Vaccine Sales (K MT) by Application
Table 33. Global Inactivated Influenza Virus Vaccine Market Size by Application
Table 34. Global Inactivated Influenza Virus Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Inactivated Influenza Virus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Inactivated Influenza Virus Vaccine Market Share by Application (2020-2025)
Table 38. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Inactivated Influenza Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Inactivated Influenza Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Inactivated Influenza Virus Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Inactivated Influenza Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Inactivated Influenza Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Inactivated Influenza Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Inactivated Influenza Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Inactivated Influenza Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Inactivated Influenza Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Inactivated Influenza Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Inactivated Influenza Virus Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Inactivated Influenza Virus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. CSL Basic Information
Table 62. CSL Inactivated Influenza Virus Vaccine Product Overview
Table 63. CSL Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. CSL Business Overview
Table 65. CSL SWOT Analysis
Table 66. CSL Recent Developments
Table 67. GSK Basic Information
Table 68. GSK Inactivated Influenza Virus Vaccine Product Overview
Table 69. GSK Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. GSK Business Overview
Table 71. GSK SWOT Analysis
Table 72. GSK Recent Developments
Table 73. Sanofi Pasteur Basic Information
Table 74. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
Table 75. Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Sanofi Pasteur Business Overview
Table 77. Sanofi Pasteur SWOT Analysis
Table 78. Sanofi Pasteur Recent Developments
Table 79. Mylan Basic Information
Table 80. Mylan Inactivated Influenza Virus Vaccine Product Overview
Table 81. Mylan Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Mylan Business Overview
Table 83. Mylan Recent Developments
Table 84. AstraZeneca Basic Information
Table 85. AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
Table 86. AstraZeneca Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Recent Developments
Table 89. Pfizer Basic Information
Table 90. Pfizer Inactivated Influenza Virus Vaccine Product Overview
Table 91. Pfizer Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Pfizer Business Overview
Table 93. Pfizer Recent Developments
Table 94. Johnson and Johnson Basic Information
Table 95. Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
Table 96. Johnson and Johnson Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Johnson and Johnson Business Overview
Table 98. Johnson and Johnson Recent Developments
Table 99. Jiangsu Jindik Biotechnology Co.Ltd Basic Information
Table 100. Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 101. Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Jiangsu Jindik Biotechnology Co.Ltd Business Overview
Table 103. Jiangsu Jindik Biotechnology Co.Ltd Recent Developments
Table 104. Beijing Kexing Biological Products Co.Ltd Basic Information
Table 105. Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 106. Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Beijing Kexing Biological Products Co.Ltd Business Overview
Table 108. Beijing Kexing Biological Products Co.Ltd Recent Developments
Table 109. Jiangsu Kangrun Biotechnology Co.Ltd Basic Information
Table 110. Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 111. Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Jiangsu Kangrun Biotechnology Co.Ltd Business Overview
Table 113. Jiangsu Kangrun Biotechnology Co.Ltd Recent Developments
Table 114. Hualan Bio Vaccines Co.Ltd Basic Information
Table 115. Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 116. Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Hualan Bio Vaccines Co.Ltd Business Overview
Table 118. Hualan Bio Vaccines Co.Ltd Recent Developments
Table 119. Dalian Yalifeng Biopharmaceutical Co.Ltd Basic Information
Table 120. Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 121. Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Dalian Yalifeng Biopharmaceutical Co.Ltd Business Overview
Table 123. Dalian Yalifeng Biopharmaceutical Co.Ltd Recent Developments
Table 124. Shanghai Institute of Biological Products Co.Ltd Basic Information
Table 125. Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 126. Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Shanghai Institute of Biological Products Co.Ltd Business Overview
Table 128. Shanghai Institute of Biological Products Co.Ltd Recent Developments
Table 129. Changchun Institute of Biological Products Co.Ltd Basic Information
Table 130. Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 131. Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Changchun Institute of Biological Products Co.Ltd Business Overview
Table 133. Changchun Institute of Biological Products Co.Ltd Recent Developments
Table 134. Lanzhou Institute of Biological Products Co.Ltd Basic Information
Table 135. Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 136. Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Lanzhou Institute of Biological Products Co.Ltd Business Overview
Table 138. Lanzhou Institute of Biological Products Co.Ltd Recent Developments
Table 139. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Basic Information
Table 140. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 141. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Business Overview
Table 143. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Recent Developments
Table 144. Emmi Chengxin Biopharmaceutical Co.Ltd Basic Information
Table 145. Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 146. Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Emmi Chengxin Biopharmaceutical Co.Ltd Business Overview
Table 148. Emmi Chengxin Biopharmaceutical Co.Ltd Recent Developments
Table 149. Global Inactivated Influenza Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 152. North America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 154. Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Inactivated Influenza Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 156. Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 158. South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Inactivated Influenza Virus Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 162. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Inactivated Influenza Virus Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 164. Global Inactivated Influenza Virus Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 165. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inactivated Influenza Virus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Inactivated Influenza Virus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Inactivated Influenza Virus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Inactivated Influenza Virus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Virus Vaccine as of 2024)
Table 10. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Inactivated Influenza Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Inactivated Influenza Virus Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Inactivated Influenza Virus Vaccine Sales by Type (K MT)
Table 26. Global Inactivated Influenza Virus Vaccine Market Size by Type (M USD)
Table 27. Global Inactivated Influenza Virus Vaccine Sales (K MT) by Type (2020-2025)
Table 28. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2020-2025)
Table 29. Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Type (2020-2025)
Table 30. Global Inactivated Influenza Virus Vaccine Market Size Share by Type (2020-2025)
Table 31. Global Inactivated Influenza Virus Vaccine Price (USD/KG) by Type (2020-2025)
Table 32. Global Inactivated Influenza Virus Vaccine Sales (K MT) by Application
Table 33. Global Inactivated Influenza Virus Vaccine Market Size by Application
Table 34. Global Inactivated Influenza Virus Vaccine Sales by Application (2020-2025) & (K MT)
Table 35. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2020-2025)
Table 36. Global Inactivated Influenza Virus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 37. Global Inactivated Influenza Virus Vaccine Market Share by Application (2020-2025)
Table 38. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2020-2025)
Table 39. Global Inactivated Influenza Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 40. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2020-2025)
Table 41. Global Inactivated Influenza Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 42. Global Inactivated Influenza Virus Vaccine Market Size Market Share by Region (2020-2025)
Table 43. North America Inactivated Influenza Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. North America Inactivated Influenza Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Inactivated Influenza Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 46. Europe Inactivated Influenza Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Inactivated Influenza Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 49. South America Inactivated Influenza Virus Vaccine Sales by Country (2020-2025) & (K MT)
Table 50. South America Inactivated Influenza Virus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 53. Global Inactivated Influenza Virus Vaccine Production (K MT) by Region(2020-2025)
Table 54. Global Inactivated Influenza Virus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Inactivated Influenza Virus Vaccine Revenue Market Share by Region (2020-2025)
Table 56. Global Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Inactivated Influenza Virus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. CSL Basic Information
Table 62. CSL Inactivated Influenza Virus Vaccine Product Overview
Table 63. CSL Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. CSL Business Overview
Table 65. CSL SWOT Analysis
Table 66. CSL Recent Developments
Table 67. GSK Basic Information
Table 68. GSK Inactivated Influenza Virus Vaccine Product Overview
Table 69. GSK Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. GSK Business Overview
Table 71. GSK SWOT Analysis
Table 72. GSK Recent Developments
Table 73. Sanofi Pasteur Basic Information
Table 74. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
Table 75. Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Sanofi Pasteur Business Overview
Table 77. Sanofi Pasteur SWOT Analysis
Table 78. Sanofi Pasteur Recent Developments
Table 79. Mylan Basic Information
Table 80. Mylan Inactivated Influenza Virus Vaccine Product Overview
Table 81. Mylan Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Mylan Business Overview
Table 83. Mylan Recent Developments
Table 84. AstraZeneca Basic Information
Table 85. AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
Table 86. AstraZeneca Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Recent Developments
Table 89. Pfizer Basic Information
Table 90. Pfizer Inactivated Influenza Virus Vaccine Product Overview
Table 91. Pfizer Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Pfizer Business Overview
Table 93. Pfizer Recent Developments
Table 94. Johnson and Johnson Basic Information
Table 95. Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
Table 96. Johnson and Johnson Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Johnson and Johnson Business Overview
Table 98. Johnson and Johnson Recent Developments
Table 99. Jiangsu Jindik Biotechnology Co.Ltd Basic Information
Table 100. Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 101. Jiangsu Jindik Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Jiangsu Jindik Biotechnology Co.Ltd Business Overview
Table 103. Jiangsu Jindik Biotechnology Co.Ltd Recent Developments
Table 104. Beijing Kexing Biological Products Co.Ltd Basic Information
Table 105. Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 106. Beijing Kexing Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Beijing Kexing Biological Products Co.Ltd Business Overview
Table 108. Beijing Kexing Biological Products Co.Ltd Recent Developments
Table 109. Jiangsu Kangrun Biotechnology Co.Ltd Basic Information
Table 110. Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 111. Jiangsu Kangrun Biotechnology Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Jiangsu Kangrun Biotechnology Co.Ltd Business Overview
Table 113. Jiangsu Kangrun Biotechnology Co.Ltd Recent Developments
Table 114. Hualan Bio Vaccines Co.Ltd Basic Information
Table 115. Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 116. Hualan Bio Vaccines Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Hualan Bio Vaccines Co.Ltd Business Overview
Table 118. Hualan Bio Vaccines Co.Ltd Recent Developments
Table 119. Dalian Yalifeng Biopharmaceutical Co.Ltd Basic Information
Table 120. Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 121. Dalian Yalifeng Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Dalian Yalifeng Biopharmaceutical Co.Ltd Business Overview
Table 123. Dalian Yalifeng Biopharmaceutical Co.Ltd Recent Developments
Table 124. Shanghai Institute of Biological Products Co.Ltd Basic Information
Table 125. Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 126. Shanghai Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Shanghai Institute of Biological Products Co.Ltd Business Overview
Table 128. Shanghai Institute of Biological Products Co.Ltd Recent Developments
Table 129. Changchun Institute of Biological Products Co.Ltd Basic Information
Table 130. Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 131. Changchun Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Changchun Institute of Biological Products Co.Ltd Business Overview
Table 133. Changchun Institute of Biological Products Co.Ltd Recent Developments
Table 134. Lanzhou Institute of Biological Products Co.Ltd Basic Information
Table 135. Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 136. Lanzhou Institute of Biological Products Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Lanzhou Institute of Biological Products Co.Ltd Business Overview
Table 138. Lanzhou Institute of Biological Products Co.Ltd Recent Developments
Table 139. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Basic Information
Table 140. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 141. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Business Overview
Table 143. Zhejiang Tian Yuan Biopharmaceutical Co.Ltd Recent Developments
Table 144. Emmi Chengxin Biopharmaceutical Co.Ltd Basic Information
Table 145. Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 146. Emmi Chengxin Biopharmaceutical Co.Ltd Inactivated Influenza Virus Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Emmi Chengxin Biopharmaceutical Co.Ltd Business Overview
Table 148. Emmi Chengxin Biopharmaceutical Co.Ltd Recent Developments
Table 149. Global Inactivated Influenza Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 152. North America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 154. Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Inactivated Influenza Virus Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 156. Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 158. South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Inactivated Influenza Virus Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Inactivated Influenza Virus Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 162. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Inactivated Influenza Virus Vaccine Price Forecast by Type (2026-2033) & (USD/KG)
Table 164. Global Inactivated Influenza Virus Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 165. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Influenza Virus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Virus Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Inactivated Influenza Virus Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Inactivated Influenza Virus Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Virus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Influenza Virus Vaccine Product Life Cycle
Figure 13. Inactivated Influenza Virus Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Virus Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Inactivated Influenza Virus Vaccine
Figure 19. Global Inactivated Influenza Virus Vaccine Market PEST Analysis
Figure 20. Global Inactivated Influenza Virus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inactivated Influenza Virus Vaccine Market Share by Type
Figure 27. Sales Market Share of Inactivated Influenza Virus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Inactivated Influenza Virus Vaccine by Type in 2024
Figure 29. Market Size Share of Inactivated Influenza Virus Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Inactivated Influenza Virus Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inactivated Influenza Virus Vaccine Market Share by Application
Figure 33. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application in 2024
Figure 35. Global Inactivated Influenza Virus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Inactivated Influenza Virus Vaccine Market Share by Application in 2024
Figure 37. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Inactivated Influenza Virus Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inactivated Influenza Virus Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inactivated Influenza Virus Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inactivated Influenza Virus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inactivated Influenza Virus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inactivated Influenza Virus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inactivated Influenza Virus Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inactivated Influenza Virus Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inactivated Influenza Virus Vaccine Market Size Market Share by Region in 2024
Figure 68. China Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inactivated Influenza Virus Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Inactivated Influenza Virus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Inactivated Influenza Virus Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inactivated Influenza Virus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inactivated Influenza Virus Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Inactivated Influenza Virus Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Inactivated Influenza Virus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Virus Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Inactivated Influenza Virus Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Inactivated Influenza Virus Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Virus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Influenza Virus Vaccine Product Life Cycle
Figure 13. Inactivated Influenza Virus Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Virus Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Inactivated Influenza Virus Vaccine
Figure 19. Global Inactivated Influenza Virus Vaccine Market PEST Analysis
Figure 20. Global Inactivated Influenza Virus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inactivated Influenza Virus Vaccine Market Share by Type
Figure 27. Sales Market Share of Inactivated Influenza Virus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Inactivated Influenza Virus Vaccine by Type in 2024
Figure 29. Market Size Share of Inactivated Influenza Virus Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Inactivated Influenza Virus Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inactivated Influenza Virus Vaccine Market Share by Application
Figure 33. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application in 2024
Figure 35. Global Inactivated Influenza Virus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Inactivated Influenza Virus Vaccine Market Share by Application in 2024
Figure 37. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Inactivated Influenza Virus Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inactivated Influenza Virus Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inactivated Influenza Virus Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inactivated Influenza Virus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inactivated Influenza Virus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inactivated Influenza Virus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inactivated Influenza Virus Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inactivated Influenza Virus Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inactivated Influenza Virus Vaccine Market Size Market Share by Region in 2024
Figure 68. China Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inactivated Influenza Virus Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Inactivated Influenza Virus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Inactivated Influenza Virus Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inactivated Influenza Virus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inactivated Influenza Virus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inactivated Influenza Virus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inactivated Influenza Virus Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Inactivated Influenza Virus Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Application (2026-2033)
